home.social

#fda — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #fda, aggregated by home.social.

  1. U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer

    First-line approval of HYRNUO® (sevabertinib) for patients with advanced HER2-mutated non-small cell lung cancer (NSCLC) follows U.S. Food…
    #Germany #DE #Europe #EU #Europa #Bayer #acceleratedapproval #adversereactions #FDA #HYRNUO #LungCancer #non-smallcelllungcancer #treatment-naïvepatients
    europesays.com/germany/101101/

  2. FDA fines six five-star hotels for food safety issues

    Six five-star hotels have been fined a total of NT$466,000 for food safety and hygiene contraventions, the Food and Drug Administration (FDA) said today. The fines followed FDA inspections of restaurants at 48 five-star and international tourist hotels to see if the…
    #dining #cooking #diet #food #Food #fda #foodsafety #Hotels #TheTaipeiTimes #台北時報
    diningandcooking.com/2836168/f

  3. FDA fines six five-star hotels for food safety issues

    Six five-star hotels have been fined a total of NT$466,000 for food safety and hygiene contraventions, the Food and Drug Administration (FDA) said today. The fines followed FDA inspections of restaurants at 48 five-star and international tourist hotels to see if the…
    #dining #cooking #diet #food #Food #fda #foodsafety #Hotels #TheTaipeiTimes #台北時報
    diningandcooking.com/2836168/f

  4. europesays.com/ch/138401/ Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis #acceptance #and #both #BTK #FDA filing #fenebrutinib #first #in #inhibitor #is #multiple #primary #progressive #receive #relapsing #Roche #Roche’s #sclerosis #the #to #US